
Immune 63: Immune, promptly
Immune
Enhanced Dengue
There's no concern that if you have a virus picked up by an antibody and binding to an F.C. receptor that it might not gain neutral pism, he says. But there are some papers that talk about how that is glycosylation site dependent. Of course, that's what gives you enhanced dengue, right? Exactly. It gets into cells that it shouldn't be in because of this interaction. Yeah. Well, maybe though, we could separate out that effect by if the virus infects a macrophage or a monocyte-derived cell. No. Is it easy to predict what host cells will support virus survival and replication? No. So, yeah
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.